Drug class · Infectious disease
Vaccines
Products in the FDA's vaccine class. Vaccines are usually reported with a CPT vaccine product code plus an immunization administration code, not with a J-code.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tenivacclostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | Clostridium tetani toxoid antigen (Formaldehyde inactivated) 5 [Lf]/.5mL; Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 2 [Lf]/.5mL | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | 49281-215 |
| Tice Bcgbacillus calmette-guerin | Bacillus calmette-guerin substrain tice live antigen 50 mg/50mL | Powder, For suspensionIntravesical | Merck Sharp & Dohme LLC | 0052-0602 |
| Twinrixhepatitis a and hepatitis b (recombinant) vaccine | Hepatitis a virus strain hm175 antigen (Formaldehyde inactivated) 720 [iU]/mL; Hepatitis b virus subtype adw2 hbsag surface protein antigen 20 ug/mL | Injection, SuspensionIntramuscular | GlaxoSmithKline Biologicals SA | 58160-815 |
| Twinrixhepatitis a and hepatitis b (recombinant) vaccine | Hepatitis a virus strain hm175 antigen (Formaldehyde inactivated) 720 [iU]/mL; Hepatitis b virus subtype adw2 hbsag surface protein antigen 20 ug/mL | Injection, SuspensionIntramuscular | A-S Medication Solutions | 50090-1645 |
| Typhim Visalmonella typhi ty2 vi polysaccharide antigen | Salmonella typhi ty2 vi polysaccharide antigen 25 ug/.5mL | Injection, SolutionIntramuscular | A-S Medication Solutions | 50090-1493 |
| Travel Immunization Detox 6033travel immunization detox | Oyster shell calcium carbonate, Crude 3 [hp_X]/59mL + 15 more ingredients | LiquidOral | Professional Complementary Health Formulas | 63083-6033 |
| Typhim Visalmonella typhi ty2 vi polysaccharide antigen | Salmonella typhi ty2 vi polysaccharide antigen 25 ug/.5mL | Injection, SolutionIntramuscular | Sanofi Vaccines US Inc. | 49281-790 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 25 [iU]/.5mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4831 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 50 [iU]/mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4096 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 50 [iU]/mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4841 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 25 [iU]/.5mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4095 |
| Varivaxvaricella virus vaccine live | Varicella-zoster virus strain oka/merck live antigen 1350 [PFU]/.5mL | Injection, Powder, Lyophilized, For suspensionSubcutaneous | Merck Sharp & Dohme LLC | 0006-4827 |
| Vaxelisdiphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine | Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 15 [Lf]/.5mL + 10 more ingredients | Injection, SuspensionIntramuscular | MSP Vaccine Company | 63361-243 |
| Vaxneuvancepneumococcal 15-valent conjugate vaccine crm197 protein adsorbed | Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen 2 ug/.5mL + 15 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4329 |
| VIR Combinationadenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex i, herpes simplex ii nosode, human herpesvirus 6a, influenzinum | Human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2357 |
| VIR Combinationadenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 and 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex i and ii nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum | Human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2539 |
| Vaccinosis Nosode 4004vaccinosis nosode | Oyster shell calcium carbonate, Crude 6 [hp_X]/59mL + 8 more ingredients | LiquidOral | Professional Complementary Health Formulas | 63083-4004 |
| Vaccistatbaptisia tinctoria, echinacea (angustifolia), hydrastis canadensis, alumina, antimonium tartaricum, mezereum, natrum muriaticum, mercurius solubilis, silicea, thuja occidentalis, malandrinum, variolinum | Baptisia tinctoria root 3 [hp_X]/mL + 11 more ingredients | LiquidOral | Energique, Inc. | 44911-0540 |
| Vaccistatbaptisia tinctoria, echinacea (angustifolia), hydrastis canadensis, alumina, antimonium tartaricum, mezereum, natrum muriaticum, mercurius solubilis, silicea, thuja occidentalis, malandrinum, variolinum | Baptisia tinctoria root 3 [hp_X]/mL + 11 more ingredients | LiquidOral | Energique, Inc. | 44911-0633 |
| Vir Combinationinfluenzinum (2020-2021), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode | Influenza a virus a/guangdong-maonan/swl1536/2019 cnic-1909 (H1n1) antigen (Formaldehyde inactivated) 12 [hp_X]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2036 |
| Vir Combinationinfluenzinum (2021-2022), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode | Influenza a virus a/victoria/2570/2019 ivr-215 (H1n1) antigen (Formaldehyde inactivated) 12 [hp_X]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2040 |
| Vir Combinationinfluenzinum (2022-2023), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode | Influenza a virus a/victoria/2570/2019 ivr-215 (H1n1) antigen (Uv, Formaldehyde inactivated) 12 [hp_X]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2062 |
| Vir Combinationadenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2022-2023) | Human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL + 10 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2123 |
| Vir Combinationadenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2023-2024) | Human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2193 |
| Viral Immune Stimulator 6017viral immune stimulator | Sodium chloride 3 [hp_X]/59mL + 19 more ingredients | LiquidOral | Professional Complementary Health Formulas | 63083-6017 |